Transperineal Laser Ablation Treatment for Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction: Protocol for a Prospective In Vivo Pilot Study

Journals

1. Spartalis E, Karagiannis S, Plakopitis N, Theodori M, Athanasiadis D, Schizas D, Spartalis M, Troupis T. Percutaneous laser ablation of cervical metastatic lymph nodes in papillary thyroid carcinoma: clinical efficacy and anatomical considerations. Expert Review of Medical Devices 2021;18(1):75 View
2. Liu R, Liu J, Duan S, Cheng S, Chang Z, Cao H, Cao G, Li Y, Li N, Zhang L. Dynamic prostatic and laser-ablated lesion volume change after transperineal laser ablation in canine: preliminary observation and its clinical significance. International Journal of Hyperthermia 2020;37(1):1260 View
3. Cai H, Fang J, Kong F, Xu C, Chen C, Wang W, Huang B. Ultrasound-guided transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a new minimally invasive interventional therapy. Acta Radiologica 2022;63(4):553 View
4. van Riel L, van Kollenburg R, Vis A, van Leeuwen P, de Reijke T, de Bruin D, Oddens J. Safety and Feasibility of Soractelite Transperineal Focal Laser Ablation for Prostate Cancer and Short-term Quality of Life Analysis from a Multicenter Pilot Study. European Urology Open Science 2022;39:48 View
5. Sessa F, Polverino P, Siena G, Bisegna C, Lo Re M, Spatafora P, Pecoraro A, Rivetti A, Moscardi L, Saladino M, Cocci A, Gacci M, Li Marzi V, Carini M, Minervini A, Campi R, Serni S. Transperineal Laser Ablation of the Prostate (TPLA) for Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction. Journal of Clinical Medicine 2023;12(3):793 View
6. Zhang W, Zhang W, Guo Q, Chen L, Meng Z, Xu Y, Cao N, Hu B, Qian B. The Design and Rationale of a Multicentre Randomised Controlled Trial Comparing Transperineal Percutaneous Laser Ablation With Transurethral Resection of the Prostate for Treating Benign Prostatic Hyperplasia. Frontiers in Surgery 2021;8 View
7. Lorenzoni V, Palla I, Manenti G, Ditonno P, de Reijke T, Turchetti G. Standard approach and future perspective for the management of benign prostatic hyperplasia from a health-economics point of view: the role of transperineal laser ablation. Frontiers in Urology 2023;3 View
8. Tafuri A, Panunzio A, De Carlo F, Luperto E, Di Cosmo F, Cavaliere A, Rizzo M, Tian Z, Shakir A, De Mitri R, Porcaro A, Cerruto M, Antonelli A, Cormio L, Carrieri G, Karakiewicz P, Abreu A, Pagliarulo V. Transperineal Laser Ablation for Benign Prostatic Enlargement: A Systematic Review and Pooled Analysis of Pilot Studies. Journal of Clinical Medicine 2023;12(5):1860 View
9. van Kollenburg R, van Riel L, Bloemen P, de Reijke T, Beerlage H, de Bruin D, Oddens J. Transperineal laser ablation as treatment for benign prostatic obstruction: Safety, feasibility and functional outcomes—A pilot study. BJUI Compass 2024;5(1):52 View
10. Cocci A, Pezzoli M, Bianco F, Blefari F, Bove P, Cornud F, De Rienzo G, Destefanis P, Di Trapani D, Giacobbe A, Giovanessi L, Laganà A, Lughezzani G, Manenti G, Muto G, Patelli G, Pinzi N, Regusci S, Russo G, Salamanca J, Salvi M, Silvestri L, Verweij F, Walser E, Bertolo R, Iacovelli V, Bertaccini A, Marchiori D, Davila H, Ditonno P, Gontero P, Iapicca G, M De Reijke T, Ricapito V, Pellegrini P, Minervini A, Serni S, Sessa F. Transperineal laser ablation of the prostate as a treatment for benign prostatic hyperplasia and prostate cancer: The results of a Delphi consensus project. Asian Journal of Urology 2024;11(2):271 View
11. Canat H, Gurbuz C, Bozkurt M. Transurethral resection of the prostate (TURP) versus transperineal laser ablation (TPLA) due to benign prostatic hyperplasia (BPH): prospective and comparative study. International Urology and Nephrology 2023;55(11):2747 View
12. Porto J, Titus R, Camargo F, Bhatia A, Ahie N, Blachman-Braun R, Malpani A, Lopategui D, Herrmann T, Marcovich R, Shah H. Minimally invasive techniques in quest of Holy Grail of surgical management of enlarged prostates: a narrative review. World Journal of Urology 2024;42(1) View
13. Dalton D, Shelton T, Rivera M. Laser Technology Advancements in the Treatment of Benign Prostatic Hypertrophy. Current Urology Reports 2024;25(4):71 View
14. Richards H, Cousins S, Scroggie D, Elliott D, Macefield R, Hudson E, Mutanga I, Shah M, Alford N, Blencowe N, Blazeby J. Examining the application of the IDEAL framework in the reporting and evaluation of innovative invasive procedures: secondary qualitative analysis of a systematic review. BMJ Open 2024;14(5):e079654 View
15. Harman A, Toth R, Mobley Z, Sartin D, Karamanian A. MRI-guided transrectal prostate laser ablation for benign prostatic hypertrophy: a retrospective cohort study. La radiologia medica 2024;129(9):1412 View
16. de Bie K, van Kollenburg R, van Riel L, Almasian M, Freund J, Bloemen P, Zweije R, Crezee J, Coolen B, Strijkers G, de Reijke T, Oddens J, van Leeuwen A, de Bruin D. Outcomes of CEM43 in Predicting Thermal Damage Induced by Focal Laser Ablation in Controlled Ex Vivo Experiments: A Comparison to Histology and MRI. Lasers in Surgery and Medicine 2024;56(8):723 View
17. van Kollenburg R, van Riel L, Oddens J, de Reijke T, van Leeuwen T, de Bruin D. Contrast-enhanced ultrasound imaging following transperineal laser ablation for lower urinary tract symptoms. Urology 2024 View